相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Mohamad-Gabriel Alameh et al.
IMMUNITY (2021)
Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles
Federica Sebastiani et al.
ACS NANO (2021)
Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection
Wei Liu et al.
JOURNAL OF VIROLOGY (2021)
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
Cory J. Knudson et al.
MOLECULAR THERAPY (2021)
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma
Paul Nghiem et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10
Courtney Mowat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Highly efficient CD4+T cell targeting and genetic recombination using engineered CD4+cell-homing mRNA-LNPs
Istvan Tombacz et al.
MOLECULAR THERAPY (2021)
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in models
Sita Awasthi et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer
Chiara Bazzichetto et al.
CELLS (2020)
Selective reactivation of STING signaling to target Merkel cell carcinoma
Wei Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
Lihong Wang-Bishop et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis
Donglim Esther Park et al.
NATURE CELL BIOLOGY (2020)
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Margaux Hubert et al.
SCIENCE IMMUNOLOGY (2020)
Old dogs, new trick: classic cancer therapies activate cGAS
Seoyun Yum et al.
CELL RESEARCH (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment
Susannah L. Hewitt et al.
CLINICAL CANCER RESEARCH (2020)
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
Xueguang Lu et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Interferon-independent STING signaling promotes resistance to HSV-1 in vivo
Livia H. Yamashiro et al.
NATURE COMMUNICATIONS (2020)
The Tumor Microenvironment of Pancreatic Cancer
Eva Karamitopoulou
CANCERS (2020)
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
Philip C. LaTourette et al.
VACCINE (2020)
An orally available non-nucleotide STING agonist with antitumor activity
Bo-Sheng Pan et al.
SCIENCE (2020)
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic
Emily N. Chin et al.
SCIENCE (2020)
Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity
Wei Liu et al.
BIOLOGY-BASEL (2020)
TMEM173 variants and potential importance to human biology and disease
Seema Patel et al.
GENES AND IMMUNITY (2019)
STING-associated lung disease in mice relies on T cells but not type I interferon
Hella Luksch et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Over-expression of low-density lipoprotein receptor-related Protein-1 is associated with poor prognosis and invasion in pancreatic ductal adenocarcinoma
Ali Gheysarzadeh et al.
PANCREATOLOGY (2019)
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
Susannah L. Hewitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features
Eva Karamitopoulou
BRITISH JOURNAL OF CANCER (2019)
Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
Chin-King Looi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
Weiqing Jing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial
Eileen M. O'Reilly et al.
JAMA ONCOLOGY (2019)
Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune Defects in the Tumor Microenvironment
Sireesha Upadhrasta et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
Sita Awasthi et al.
SCIENCE IMMUNOLOGY (2019)
Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice
Lisa Munakata et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Novel TMEM173 Mutation and the Role of Disease Modifying Alleles
Salla Keskitalo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Pro-inflammation Associated with a Gain-of-Function Mutation (R284S) in the Innate Immune Sensor STING
Hiroyasu Konno et al.
CELL REPORTS (2018)
LBA15Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas
K J Harrington et al.
ANNALS OF ONCOLOGY (2018)
Design of amidobenzimidazole STING receptor agonists with systemic activity
Joshi M. Ramanjulu et al.
NATURE (2018)
The biology and treatment of Merkel cell carcinoma: current understanding and research priorities
Paul W. Harms et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
Kelsey E. Sivick et al.
CELL REPORTS (2018)
Familial chilblain lupus due to a gain-of-function mutation in STING
Nadja Konig et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
Isabelle Melki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
Silvia Cerboni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
Bridget Larkin et al.
JOURNAL OF IMMUNOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
Signalling strength determines proapoptotic functions of STING
Muhammet F. Gulen et al.
NATURE COMMUNICATIONS (2017)
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Julienne L. Carstens et al.
NATURE COMMUNICATIONS (2017)
Trafficking-Mediated STING Degradation Requires Sorting to Acidified Endolysosomes and CanBe Targeted to Enhance Anti-tumor Response
Vijay K. Gonugunta et al.
CELL REPORTS (2017)
Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis
Jingwei Cheng et al.
PLOS PATHOGENS (2017)
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
Jeremy B. Foote et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Epigenetic regulation of PD-L1 expression and pancreatic cancer response to checkpoint immunotherapy
Chunwan Lu et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Merkel cell carcinoma
Juergen C. Becker et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3
Moritz M. Gaidt et al.
CELL (2017)
PD-1/PD-L1 and immunotherapy for pancreatic cancer
Mengyu Feng et al.
CANCER LETTERS (2017)
Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis
Tianli Xia et al.
CANCER RESEARCH (2016)
Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
Wei Liu et al.
CELL HOST & MICROBE (2016)
Role of immune cells in pancreatic cancer from bench to clinical application An updated review
Jae Hyuck Chang et al.
MEDICINE (2016)
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Qi Chen et al.
NATURE IMMUNOLOGY (2016)
Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
Tianli Xia et al.
CELL REPORTS (2016)
Lipid Nanoparticle-mediated siRNA Transfer Against PCTAIRE1/PCTK1/Cdk16 Inhibits In Vivo Cancer Growth
Teruki Yanagi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Merkel cell carcinoma and Merkel cell polyomavirus: a systematic review and meta-analysis
J. Santos-Juanes et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease
Nicole Dobbs et al.
CELL HOST & MICROBE (2015)
Molecular Pathways: Targeting the Stimulator of InterferonGenes(STING) in the Immunotherapyof Cancer
Leticia Corrales et al.
CLINICAL CANCER RESEARCH (2015)
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Olivier Demaria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens
Cierra N. Casson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
Timothy J. Zumwalt et al.
ONCOTARGET (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy A Mimic of Childhood Granulomatosis With Polyangiitis
Justine Munoz et al.
JAMA DERMATOLOGY (2015)
Single Amino Acid Change in STING Leads to Constitutive Active Signaling
Eric D. Tang et al.
PLOS ONE (2015)
STING: infection, inflammation and cancer
Glen N. Barber
NATURE REVIEWS IMMUNOLOGY (2015)
BRD4 regulates Nanog expression in mouse embryonic stem cells and preimplantation embryos
W. Liu et al.
CELL DEATH AND DIFFERENTIATION (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations
Nadia Jeremiah et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling
Xin Cai et al.
MOLECULAR CELL (2014)
Activated STING in a Vascular and Pulmonary Syndrome
Y. Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Inflammation-driven carcinogenesis is mediated through STING
Jeonghyun Ahn et al.
NATURE COMMUNICATIONS (2014)
Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses
Daxing Gao et al.
SCIENCE (2013)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Katalin Kariko et al.
NUCLEIC ACIDS RESEARCH (2011)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
Bart R. Anderson et al.
NUCLEIC ACIDS RESEARCH (2010)
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Katalin Kariko et al.
MOLECULAR THERAPY (2008)
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Carolyn E. Clark et al.
CANCER RESEARCH (2007)
Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA
K Karikó et al.
IMMUNITY (2005)
分享论文
